Research map: Plasma concentrations of nirmatrelvir and molnupiravir required for inhibition of SARS-CoV-2 replication differ between rhesus macaques and humans Back to the article
Papers in this map Remdesivir for the Treatment of Covid-19 — Final Report · John H. Beigel · 2020 · 7757 citations · Cited by this paperPER-14, a β-lactamase variant with reduced sensitivity to avibactam and relebactam · 2026 · RelatedImbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 · Daniel Blanco-Melo · 2020 · 4571 citations · Cited by this paperAn Achilles' heel for methicillin-resistant Staphylococcus aureus ? Re-evaluating β-lactam susceptibility of MRSA · 2026 · RelatedRemdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial · Yeming Wang · 2020 · 3664 citations · Cited by this paperA community-based One Health approach to the pandemic dynamics of Escherichia coli ST131 · 2026 · RelatedSingle-cell landscape of bronchoalveolar immune cells in patients with COVID-19 · Mingfeng Liao · 2020 · 2780 citations · Cited by this paperDevelopment of domain-specific probes of Plasmodium falciparum heat shock protein 70-1 · 2026 · RelatedOral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 · Jennifer Hammond · 2022 · 2231 citations · Cited by this paperPopulation pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV · 2026 · RelatedAn oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19 · Dafydd R. Owen · 2021 · 1996 citations · Cited by this paperPrimaquine-derived 5,6-orthoquinone concentrations in urine associated with CYP2D6 genotype-predicted phenotype and blood methemoglobin levels · 2026 · RelatedIdentifying airborne transmission as the dominant route for the spread of COVID-19 · Renyi Zhang · 2020 · 1329 citations · Cited by this paperSelective digestive decontamination and antimicrobial resistance: defining thresholds before global implementation · 2026 · RelatedEarly Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients · Robert Gottlieb · 2021 · 1298 citations · Cited by this paperRecalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam · 2026 · RelatedCorrelates of protection against SARS-CoV-2 in rhesus macaques · Katherine McMahan · 2020 · 1240 citations · Cited by this paperNagX, a periplasmic β- N -acetylglucosaminidase, contributes to NagZ-independent β-lactamase expression in Stenotrophomonas maltophilia · 2026 · RelatedSimulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility · Jasper Fuk‐Woo Chan · 2020 · 1194 citations · Cited by this paperAnti-RSV drug screening and inhibition of RSV infection by lapatinib through the IL-17 pathway · 2026 · RelatedComparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model · Barry Rockx · 2020 · 988 citations · Cited by this paperProphylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection · Emmie de Wit · 2020 · 949 citations · Cited by this paperKinetics of Influenza A Virus Infection in Humans · Prasith Baccam · 2006 · 820 citations · Cited by this paperRespiratory disease in rhesus macaques inoculated with SARS-CoV-2 · Vincent J. Munster · 2020 · 771 citations · Cited by this paperMechanism of molnupiravir-induced SARS-CoV-2 mutagenesis · Florian Kabinger · 2021 · 751 citations · Cited by this paperClinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2 · Brandi N. Williamson · 2020 · 738 citations · Cited by this paperBiomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis · Preeti Malik · 2020 · 653 citations · Cited by this paperAerosol transmission of SARS-CoV-2? Evidence, prevention and control · Song Tang · 2020 · 584 citations · Cited by this paperSurgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19) · Jasper Fuk‐Woo Chan · 2020 · 560 citations · Cited by this paperPrimary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques · Wei Deng · 2020 · 487 citations · Cited by this paperHydroxychloroquine use against SARS-CoV-2 infection in non-human primates · Pauline Maisonnasse · 2020 · 363 citations · Cited by this paperCharacterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia · Märt Toots · 2019 · 342 citations · Cited by this paperDose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs · Lin Shen · 2008 · 336 citations · Cited by this paperThe interferon landscape along the respiratory tract impacts the severity of COVID-19 · Benedetta Sposito · 2021 · 290 citations · Cited by this paperThe SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans · Yueh–Ming Loo · 2022 · 219 citations · Cited by this paperKinetics of Coinfection with Influenza A Virus and Streptococcus pneumoniae · Amber M. Smith · 2013 · 211 citations · Cited by this paperPotency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response · Ashish Kumar Goyal · 2020 · 202 citations · Cited by this paperClinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2 · Brandi N. Williamson · 2020 · 183 citations · Cited by this paperClonal expansion and activation of tissue-resident memory-like T H 17 cells expressing GM-CSF in the lungs of patients with severe COVID-19 · Yu Zhao · 2021 · 176 citations · Cited by this paperSource: OpenAlex (CC0)